New Insights Show that Cannabis Is Not a ‘Gateway’ Drug

For various reasons, there is a long-standing belief that cannabis is a “gateway drug,” which opens the door to the use of harder, more dangerous substances.  As acceptance our acceptance and understanding of cannabis continues to grow, this belief is slowly and surely being debunked.  For example, a recent study¹ looked at the relationship between cannabis use as a predictor to the use of, arguably, the most dangerous of drug classes today – opioids.  In the study, researchers provided evidence that not only should cannabis not be viewed as a gateway drug to opioid use, but it could potentially be a solution to avoidance in some instances.

Where the Label Came From

Before diving into the details of the study, it is important to understand when and why cannabis was labeled as a gateway drug.  This first occurred around the 1930s when sensationalist efforts by influential individuals like Harry Anslinger and the government alike pushed the narrative on the public.  This was no more evident than through the release of propaganda like the infamous film ‘Reefer Madness’ which exaggerated the effects of cannabis to instill fear in the public.

By the 1980s, during the height of the War on Drugs and the unmitigated failure that was the Just Say No initiatives, the idea of cannabis being a gateway drug was a key part of anti-drug campaigns.  It was used to suggest that cannabis consumption would inevitably lead to experimentation with and addiction to harder drugs such as cocaine and heroin.  Looking back, we now know that this claim was largely based on correlational data that lacked scientific backing, and as the widely known saying goes – correlation does not imply causation.

The phrase ‘correlation does not infer causation’ underscores the flawed logic of the gateway drug theory, which ignored broader socioeconomic, environmental, and individual factors driving substance use patterns. By relying on weak correlations, the War on Drugs policies perpetuated misconceptions about cannabis and diverted attention from the underlying causes of addiction.  Only now, decades later, has this longstanding theory shifted.

Debunking the Gateway Theory

As mentioned, a recently published study examined links between cannabis use and subsequent use of other substances.  In it, researchers found no causal link between cannabis consumption and harder drugs like opioids.  In fact, their analysis revealed a variety of other factors that presented as much more significant predictors of substance abuse.  These included:

• socioeconomic status
• peer influence
• mental health conditions

Simply put – the study’s findings undermine the gateway drug narrative and instead suggest that cannabis use is part of a broader picture rather than being directly responsible for addiction to other substances.

Can Cannabis Reduce Opioid Use?

Interestingly, the same study also analyzed the impact of medical cannabis laws on opioid use.  It was found that in States where medical cannabis is already legal, opioid use and overdoses have significantly declined.  This further strengthens past findings of a similar nature in a study² from 2014 that looked at a link between cannabis use and opioid deaths.

The researchers found that in cases where patients needed to manage pain, they were able to substitute cannabis for prescription opioids.  This resulted in fewer opioid prescriptions and a reduced risk of addiction.  Unfortunately, while this may be true, there remains a disconnect in the real world between doctors and sufferers of chronic pain.  We highlighted this in a look at another recent study³, which showed a continued hesitancy to prescribe cannabis over opioids despite the potential to avoid addictions and an overall improvement in quality of life.

According to the Centers for Disease Control and Prevention (CDC), over 80,000 opioid overdose deaths occurred in the United States in 2021 alone.  Needless to say, this should underscore the urgency of finding alternative pain management solutions.  Meanwhile, deaths attributed to cannabis use are exceedingly rare and typically the result of comorbidities.

Final Thoughts

While more research is needed, our increased understanding of cannabis is making it clear that the gateway drug theory is a relic of the past.  Cannabis’s potential to reduce opioid dependency, improve chronic pain management, and enhance health outcomes should mean a thorough revisiting of outdated policies.  By embracing the latest scientific insights, society can move toward a more apt treatment and usage of cannabis to benefit from what it can offer modern healthcare.

Study Reference:

<sup>1. Martins, S. S., Bruzelius, E., Mauro, C. M., Santaella-Tenorio, J., Boustead, A. E., Wheeler-Martin, K., Samples, H., Hasin, D. S., Fink, D. S., Rudolph, K. E., Crystal, S., Davis, C. S., & Cerdá, M. (2025). The relationship of medical and recreational cannabis laws with opioid misuse and opioid use disorder in the USA: Does it depend on prior history of cannabis use? International Journal of Drug Policy, 136, 104687. https://doi.org/10.1016/j.drugpo.2024.104687
2. Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Internal Medicine, 174(10), 1668–1673. https://doi.org/10.1001/jamainternmed.2014.4005
3. Stone, E. M., Tormohlen, K., Bicket, M. C., & McGinty, E. E. (2024). Support for expanding access to cannabis among physicians and adults with chronic pain. JAMA Network Open, 7(9), e2435843. https://doi.org/10.1001/jamanetworkopen.2024.35843</sup>